× Alert! To view the full data details, please Login or Register. Synopsis: VC SBIR-STTR Data Acquired Firms 2,796 (8.68%) Acquiring Entities 1,771 Transactions 2,868 M&A Deals Value $536.5B VC Funded Firms 1,286 Total VC Investment $47.9B Distribution of M&A transactions SBIR M&A Deals Value: non-VC & VC Funded Firms (last 10 years) SBIR M&A Num Deals: non-VC & VC Funded Firms (last 10 years) SBIR M&A Key Takeaways SBIR M&A by Price Paid: non-VC & VC Funded Firms Featured SBIR Firm Gilead Sciences Inc Gilead Sciences Inc. is an independent biopharmaceutical company focused to discovery, development and commercialization of proprietary therapeutics for important viral diseases, including the currently marketed product VISTIDE (cidofovir injection) ... see more www.gilead.com | (650) 574-3000 SBIR M&A & Partnering News Date Title Nov 13 2023 Selecta Biosciences Announces Merger with Cartesian Therapeutics Aug 22 2023 Grander Closes Acquisition of PolarityTE, Inc. Assets Aug 08 2023 Arcfield Acquires Strategic Technology Consulting Aug 08 2023 Alchemist Completes Acquisition of Aqueous Resources LLC, a Leader in Industrial Brine Pre-Treatment Solutions and Direct Lithium Extraction Jul 17 2023 Novartis Acquires DTx Pharma in Potential $1B Deal Explanation ×
